| For: | Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 2007; 13(1): 22-38 [PMID: 17206752 DOI: 10.3748/wjg.v13.i1.22] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i1/22.htm |
| Number | Citing Articles |
| 1 |
Kazuto Tajiri, Tatsuhiko Ozawa, Aishun Jin, Yoshiharu Tokimitsu, Masami Minemura, Hiroyuki Kishi, Toshiro Sugiyama, Atsushi Muraguchi. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine. Antiviral Research 2010; 87(1) doi: 10.1016/j.antiviral.2010.04.006
|
| 2 |
Oscar Lamas Longarela, Tobias T. Schmidt, Katrin Schöneweis, Raffaella Romeo, Heiner Wedemeyer, Stephan Urban, Andreas Schulze, Birke Bartosch. Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors. PLoS ONE 2013; 8(3) doi: 10.1371/journal.pone.0058340
|
| 3 |
Marjoleine L. Op den Brouw, Rekha S. Binda, Teunis B.H. Geijtenbeek, Harry L.A. Janssen, Andrea M. Woltman. The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells. Virology 2009; 393(1) doi: 10.1016/j.virol.2009.07.015
|
| 4 |
Nattanan Panjaworayan, Stephan K Roessner, Andrew E Firth, Chris M Brown. HBVRegDB: Annotation, comparison, detection and visualization of regulatory elements in hepatitis B virus sequences. Virology Journal 2007; 4(1) doi: 10.1186/1743-422X-4-136
|
| 5 |
Ning Chai, Ho Eun Chang, Emmanuelle Nicolas, Ziying Han, Michal Jarnik, John Taylor. Properties of Subviral Particles of Hepatitis B Virus. Journal of Virology 2008; 82(16) doi: 10.1128/JVI.00561-08
|
| 6 |
Jochen M. Wettengel, Benjamin J. Burwitz. Innovative HBV Animal Models Based on the Entry Receptor NTCP. Viruses 2020; 12(8) doi: 10.3390/v12080828
|
| 7 |
Christopher Peterson, Joshua Miller, Brent Ryckman, Vitaly V Ganusov. Apparent cooperativity between human CMV virions introduces errors in conventional methods of calculating multiplicity of infection. eLife 2026; 14 doi: 10.7554/eLife.108921.3
|
| 8 |
Yasmine R. Vieira, Moyra M. Portilho, Flávia F. Oliveira, Alexandro Guterres, Débora Regina L dos Santos, Lívia M. Villar, Santiago Mirazo, Juan Arbiza, Luana A.G. Dimache, Fernando Q. Almeida, Martha L. Brandão, José Luís P. Cordeiro, Fabiana L. Rocha, Fernanda C. Azevedo, Frederico G. Lemos, João Bosco V. Campos, Gabriel C. Macedo, Heitor M. Herrera, Igor Alexandre S. Péres, Namor P. Zimmermann, Ubiratan Piovezan, Aiesca O. Pellegrin, Vanessa S. de Paula, Marcelo A. Pinto. Evaluation of HBV-Like Circulation in Wild and Farm Animals from Brazil and Uruguay. International Journal of Environmental Research and Public Health 2019; 16(15) doi: 10.3390/ijerph16152679
|
| 9 |
Nicole L. B. Corder, Bhargav Koduru, Seung Bum Park, Yiyan Wang, Jinah Choi. Studies on Hepatic Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice 2015; doi: 10.1007/978-3-319-15539-5_11
|
| 10 |
Stephan Urban, Ralf Bartenschlager, Ralf Kubitz, Fabien Zoulim. Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes. Gastroenterology 2014; 147(1) doi: 10.1053/j.gastro.2014.04.030
|
| 11 |
Romuald Patient, Christophe Hourioux, Philippe Roingeard. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cellular Microbiology 2009; 11(11) doi: 10.1111/j.1462-5822.2009.01363.x
|
| 12 |
Yu Xiao, Chunlan Liu, Wei Tang, Haiwei Zhang, Xulin Chen. Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02638
|
| 13 |
Siwei Chen, Lan Zhang, Yi Chen, Leilei Fu. Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential. Journal of Medicinal Chemistry 2022; 65(19) doi: 10.1021/acs.jmedchem.2c01097
|
| 14 |
C. Nelson Hayes, Kazuaki Chayama. HBV culture and infectious systems. Hepatology International 2016; 10(4) doi: 10.1007/s12072-016-9712-y
|
| 15 |
Koichi Watashi, Stephan Urban, Wenhui Li, Takaji Wakita. NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry. International Journal of Molecular Sciences 2014; 15(2) doi: 10.3390/ijms15022892
|
| 16 |
Yoshihito Nagura, Kei Fujiwara, Kentaro Matsuura, Etsuko Iio, Yasuhito Tanaka, Hiromi Kataoka. Complex structural variations in non-human primate hepatitis B virus. Virology Journal 2021; 18(1) doi: 10.1186/s12985-021-01667-0
|
| 17 |
Carmen L. Delgado, Elena Núñez, Belén Yélamos, Julián Gómez-Gutiérrez, Darrell L. Peterson, Francisco Gavilanes. Spectroscopic Characterization and Fusogenic Properties of PreS Domains of Duck Hepatitis B Virus. Biochemistry 2012; 51(42) doi: 10.1021/bi3008406
|
| 18 |
Andreas Schulze, Philippe Gripon, Stephan Urban. Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans. Hepatology 2007; 46(6) doi: 10.1002/hep.21896
|
| 19 |
Catalina Petrareanu, Alina Macovei, Izabela Sokolowska, Alisa G. Woods, Catalin Lazar, Gabriel L. Radu, Costel C. Darie, Norica Branza-Nichita, Wang-Shick Ryu. Comparative Proteomics Reveals Novel Components at the Plasma Membrane of Differentiated HepaRG Cells and Different Distribution in Hepatocyte- and Biliary-Like Cells. PLoS ONE 2013; 8(8) doi: 10.1371/journal.pone.0071859
|
| 20 |
Jie Wang, Hongxin Huang, Yongzhen Liu, Ran Chen, Ying Yan, Shu Shi, Jingyuan Xi, Jun Zou, Guangxin Yu, Xiaoyu Feng, Fengmin Lu. Hepatitis B Virus Infection. Advances in Experimental Medicine and Biology 2020; 1179 doi: 10.1007/978-981-13-9151-4_2
|
| 21 |
Marie-Jeanne Marion, Olivier Hantz, David Durantel. Hepatocytes. Methods in Molecular Biology 2010; 640 doi: 10.1007/978-1-60761-688-7_13
|
| 22 |
Hsiu-Chen Huang, Chun-Chi Chen, Wen-Cheng Chang, Mi-Hua Tao, Cheng Huang. Entry of Hepatitis B Virus into Immortalized Human Primary Hepatocytes by Clathrin-Dependent Endocytosis. Journal of Virology 2012; 86(17) doi: 10.1128/JVI.00873-12
|
| 23 |
Yi Ni, Florian A. Lempp, Stefan Mehrle, Shirin Nkongolo, Christina Kaufman, Maria Fälth, Jan Stindt, Christian Königer, Michael Nassal, Ralf Kubitz, Holger Sültmann, Stephan Urban. Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes. Gastroenterology 2014; 146(4) doi: 10.1053/j.gastro.2013.12.024
|
| 24 |
Anneke Funk, Mouna Mhamdi, Heinz Hohenberg, Jörg Heeren, Rudolph Reimer, Carsten Lambert, Reinhild Prange, Hüseyin Sirma. Duck Hepatitis B Virus Requires Cholesterol for Endosomal Escape during Virus Entry. Journal of Virology 2008; 82(21) doi: 10.1128/JVI.00422-08
|
| 25 |
Corinna M. Bremer, Christiane Bung, Nicole Kott, Martin Hardt, Dieter Glebe. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cellular Microbiology 2009; 11(2) doi: 10.1111/j.1462-5822.2008.01250.x
|
| 26 |
Wen‐Chun Liu, I‐Chin Wu, Yen‐Chien Lee, Chih‐Peng Lin, Ji‐Hong Cheng, Yih‐Jyh Lin, Chia‐Jui Yen, Pin‐Nan Cheng, Pei‐Fu Li, Yi‐Ting Cheng, Pei‐Wen Cheng, Koun‐Tem Sun, Shu‐Ling Yan, Jia‐Jhen Lin, Jui‐Chu Yang, Kung‐Chao Chang, Cheng‐Hsun Ho, Vincent S Tseng, Bill Chia‐Han Chang, Jaw‐Ching Wu, Ting‐Tsung Chang. Hepatocellular carcinoma‐associated single‐nucleotide variants and deletions identified by the use of genome‐wide high‐throughput analysis of hepatitis B virus. The Journal of Pathology 2017; 243(2) doi: 10.1002/path.4938
|
| 27 |
Masataka Tsuge. Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?. Viruses 2021; 13(10) doi: 10.3390/v13101920
|
| 28 |
Mingkuan Su, Huijuan Chen, Yongbin Zeng, Tianbin Chen, Jing Chen, Ling Jiang, Can Liu, Bin Yang, Qishui Ou. Association of Genetic Variation of CIITA and NTCP with Chronic Hepatitis B Virus Infection in Han Chinese Populations. Hepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.33646
|
| 29 |
Yuri Churin, Karuna Irungbam, Christoph S. Imiela, David Schwarz, Hans-Joachim Mollenkopf, Uta Drebber, Margarete Odenthal, Oleg Pak, Magdalena Huber, Dieter Glebe, Martin Roderfeld, Elke Roeb. Lipid Storage and Interferon Response Determine the Phenotype of Ground Glass Hepatocytes in Mice and Humans. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(2) doi: 10.1016/j.jcmgh.2021.03.009
|
| 30 |
Maura Dandri, Stephen Locarnini. New insight in the pathobiology of hepatitis B virus infection. Gut 2012; 61(Suppl 1) doi: 10.1136/gutjnl-2012-302056
|
| 31 |
Kazuaki Chayama, C. Nelson Hayes. Hepatitis B Virus and Liver Disease. 2018; doi: 10.1007/978-981-10-4843-2_2
|
| 32 |
Avik Biswas, Rajesh Panigrahi, Arup Banerjee, Manisha Pal, Binay Krishna De, Sekhar Chakrabarti, Runu Chakravarty. Differential pattern of pre-S mutations/deletions and its association with hepatitis B virus genotypes in Eastern India. Infection, Genetics and Evolution 2012; 12(2) doi: 10.1016/j.meegid.2012.01.007
|
| 33 |
Chris Lauber, Stefan Seitz, Simone Mattei, Alexander Suh, Jürgen Beck, Jennifer Herstein, Jacob Börold, Walter Salzburger, Lars Kaderali, John A.G. Briggs, Ralf Bartenschlager. Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses. Cell Host & Microbe 2017; 22(3) doi: 10.1016/j.chom.2017.07.019
|
| 34 |
Takeshi Kasuya, Joohee Jung, Rie Kinoshita, Yasumasa Goh, Takashi Matsuzaki, Masumi Iijima, Nobuo Yoshimoto, Katsuyuki Tanizawa, Shun’ichi Kuroda. Liposomes, Part F. Methods in Enzymology 2009; 464 doi: 10.1016/S0076-6879(09)64008-8
|
| 35 |
Xiaochen Tian, Chao Zhao, Hongguang Zhu, Weimin She, Jiming Zhang, Jing Liu, Lanjuan Li, Shusen Zheng, Yu-Mei Wen, Youhua Xie. Hepatitis B Virus (HBV) Surface Antigen Interacts with and Promotes Cyclophilin A Secretion: Possible Link to Pathogenesis of HBV Infection. Journal of Virology 2010; 84(7) doi: 10.1128/JVI.02555-09
|
| 36 |
Yinli Yang, Qiuju Han, Cai Zhang, Min Xiao, Jian Zhang. Hepatitis B virus antigens impair NK cell function. International Immunopharmacology 2016; 38 doi: 10.1016/j.intimp.2016.06.015
|
| 37 |
Alina Macovei, Cristina Radulescu, Catalin Lazar, Stefana Petrescu, David Durantel, Raymond A. Dwek, Nicole Zitzmann, Norica Branza Nichita. Hepatitis B Virus Requires Intact Caveolin-1 Function for Productive Infection in HepaRG Cells. Journal of Virology 2010; 84(1) doi: 10.1128/JVI.01207-09
|
| 38 |
Xuan Liu, Lunzhi Yuan, Liang Zhang, Yalin Mu, Xiaoling Li, Chao Liu, Peng Lv, Yali Zhang, Tong Cheng, Quan Yuan, Ningshao Xia, Xiaoyuan Chen, Gang Liu. Bioinspired Artificial Nanodecoys for Hepatitis B Virus. Angewandte Chemie International Edition 2018; 57(38) doi: 10.1002/anie.201807212
|
| 39 |
Bin Chen, Min Lian, Shili Xu, Ming Luo, Xiaofeng Zheng. A chemical lipid modification of recombinant preS antigen to study the mechanism of HBV attachment to the host cell. Journal of Biotechnology 2008; 137(1-4) doi: 10.1016/j.jbiotec.2008.06.010
|
| 40 |
Saravana Mani, Ourania Andrisani. Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells. Genes 2018; 9(3) doi: 10.3390/genes9030137
|
| 41 |
Jeong-Hun Kang, Riki Toita, Daisuke Asai, Tetsuji Yamaoka, Masaharu Murata. Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus. Journal of Virological Methods 2014; 201 doi: 10.1016/j.jviromet.2014.02.013
|
| 42 |
Huan Yan, Yang Liu, Jianhua Sui, Wenhui Li. NTCP opens the door for hepatitis B virus infection. Antiviral Research 2015; 121 doi: 10.1016/j.antiviral.2015.06.002
|
| 43 |
Md. Golzar Hossain, Sharmin Akter, Eriko Ohsaki, Keiji Ueda. Impact of the Interaction of Hepatitis B Virus with Mitochondria and Associated Proteins. Viruses 2020; 12(2) doi: 10.3390/v12020175
|
| 44 |
|
| 45 |
Samina Baig, Syed H. Abidi, Zahid Azam, Shahid Majid, Saeed Khan, Muhammad R. Khanani, Syed Ali. Evolution of HBV S‐gene in the backdrop of HDV co‐infection. Journal of Medical Virology 2018; 90(8) doi: 10.1002/jmv.25200
|
| 46 |
Jun Ji, Shuqi Xu, Wanyu Li, Xin Xu, Yunchao Kan, Lunguang Yao, Yingzuo Bi, Qingmei Xie. Genome analysis and recombination characterization of duck hepatitis B virus isolated from ducks and geese in central China, 2017 to 2019. Poultry Science 2023; 102(6) doi: 10.1016/j.psj.2023.102641
|
| 47 |
Zina S. Valaydon, Stephen A. Locarnini. The virological aspects of hepatitis B. Best Practice & Research Clinical Gastroenterology 2017; 31(3) doi: 10.1016/j.bpg.2017.04.013
|
| 48 |
J.W. Zea-Mazo, Y.A. Negrette-Mejía, W. Cardona-Maya. Virus of Sexual transmission: Semen and virus relationship. Actas Urológicas Españolas (English Edition) 2010; 34(10) doi: 10.1016/S2173-5786(10)70212-2
|
| 49 |
Yinli Yang, Qiuju Han, Zhaohua Hou, Cai Zhang, Zhigang Tian, Jian Zhang. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction. Cellular & Molecular Immunology 2017; 14(5) doi: 10.1038/cmi.2016.24
|
| 50 |
Shan Zhong, Shi-yao Zhang, Hui-jie Xing, Xiao-tan Zhang, Guang Wang, Yong-ping Bao, Jiang-nan Fu, Xuesong Yang. Revealing histological and morphological features of female reproductive system in tree shrew (Tupaia belangeri). Zoomorphology 2018; 137(1) doi: 10.1007/s00435-017-0374-7
|
| 51 |
Maura Dandri, Joerg Petersen. Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential. Clinical Infectious Diseases 2016; 62(suppl 4) doi: 10.1093/cid/ciw023
|
| 52 |
Jeong-Hun Kang, Riki Toita, Masaharu Murata. Liver cell-targeted delivery of therapeutic molecules. Critical Reviews in Biotechnology 2016; 36(1) doi: 10.3109/07388551.2014.930017
|
| 53 |
Barbara Schroeder, Mark A. McNiven. Importance of Endocytic Pathways in Liver Function and Disease. Comprehensive Physiology 2014; 4(4) doi: 10.1002/j.2040-4603.2014.tb00588.x
|
| 54 |
|
| 55 |
Anna Balasso, Stefano Salmaso, Patrizia Pontisso, Antonio Rosato, Santina Quarta, Alessio Malfanti, Francesca Mastrotto, Paolo Caliceti. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences 2017; 103 doi: 10.1016/j.ejps.2017.02.016
|
| 56 |
Amir Hossein Esfandiari, Hadis Hajipir Farkhani, Zahra Hashemi Javan, Arastoo Vojdani, Mahla Velayati, Hanie Mahaki, Zahra Meshkat, Hamed Manoochehri, Amir Avan, Hamid Tanzadehpanah. Biosensors for Detection of Hepatitis B Virus: Review. Current Medicinal Chemistry 2025; 32(23) doi: 10.2174/0109298673295474240531100312
|
| 57 |
Maike C Jürgens, Judit Vörös, Gilles J P Rautureau, Dale A Shepherd, Valerie E Pye, Jimmy Muldoon, Christopher M Johnson, Alison E Ashcroft, Stefan M V Freund, Neil Ferguson. The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry. Nature Chemical Biology 2013; 9(9) doi: 10.1038/nchembio.1294
|
| 58 |
Mitsuo Yamada, Ayako Oeda, Joohee Jung, Masumi Iijima, Nobuo Yoshimoto, Tomoaki Niimi, Seong-Yun Jeong, Eun Kyung Choi, Katsuyuki Tanizawa, Shun'ichi Kuroda. Hepatitis B virus envelope L protein-derived bio-nanocapsules: Mechanisms of cellular attachment and entry into human hepatic cells. Journal of Controlled Release 2012; 160(2) doi: 10.1016/j.jconrel.2011.11.004
|
| 59 |
Dieter Glebe, Alexander König. Molecular Virology of Hepatitis B Virus and Targets for Antiviral Intervention. Intervirology 2014; 57(3-4) doi: 10.1159/000360946
|
| 60 |
Benedikte Serruys, Freya Van Houtte, Phebe Verbrugghe, Geert Leroux‐Roels, Peter Vanlandschoot. Llama‐derived single‐domain intrabodies inhibit secretion of hepatitis B virions in mice†. Hepatology 2009; 49(1) doi: 10.1002/hep.22609
|
| 61 |
Wolfram H. Gerlich. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Medical Microbiology and Immunology 2015; 204(1) doi: 10.1007/s00430-014-0373-y
|
| 62 |
Zandiswa Gulube, Michael Chirara, Michael Kew, Yasuhito Tanaka, Masashi Mizokami, Anna Kramvis. Molecular characterization of hepatitis B virus isolates from Zimbabwean blood donors. Journal of Medical Virology 2011; 83(2) doi: 10.1002/jmv.21954
|
| 63 |
B. Niedre‐Otomere, A. Bogdanova, D. Skrastina, A. Zajakina, R. Bruvere, V. Ose, W. H. Gerlich, H. Garoff, P. Pumpens, D. Glebe, T. Kozlovska. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre‐S1 antigens induce broadly reactive neutralizing antibodies. Journal of Viral Hepatitis 2012; 19(9) doi: 10.1111/j.1365-2893.2012.01594.x
|
| 64 |
|
| 65 |
Tomasz Pniewski. Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases. 2014; doi: 10.1007/978-1-4939-0850-9_10
|
| 66 |
Joshua Buse, Anas El-Aneed. Properties, Engineering and Applications of Lipid-Based Nanoparticle Drug-Delivery Systems: Current Research and Advances. Nanomedicine 2010; 5(8) doi: 10.2217/nnm.10.107
|
| 67 |
|
| 68 |
Ran Hong, Weiya Bai, Jianwei Zhai, Wei Liu, Xinyan Li, Jiming Zhang, Xiaoxian Cui, Xue Zhao, Xiaoli Ye, Qiang Deng, Pierre Tiollais, Yumei Wen, Jing Liu, Youhua Xie. Novel Recombinant Hepatitis B Virus Vectors Efficiently Deliver Protein and RNA Encoding Genes into Primary Hepatocytes. Journal of Virology 2013; 87(12) doi: 10.1128/JVI.03328-12
|
| 69 |
Hans-Jürgen Netter, Shau-Feng Chang, Michael Bruns. Host-Range and Pathogenicity of Hepatitis B Viruses. Future Virology 2008; 3(1) doi: 10.2217/17460794.3.1.83
|
| 70 |
Joerg Petersen, Maura Dandri, Walter Mier, Marc Lütgehetmann, Tassilo Volz, Fritz von Weizsäcker, Uwe Haberkorn, Lutz Fischer, Joerg-Matthias Pollok, Berit Erbes, Stefan Seitz, Stephan Urban. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nature Biotechnology 2008; 26(3) doi: 10.1038/nbt1389
|
| 71 |
Ajay Kumar, Manisha Dwivedi, S. P. Misra, Sushil Narang, Balesh Kumar Tiwari, Renu Pandey. Clinical Profile, Genotype and Management Updates of Hepatitis B Virus. Indian Journal of Virology 2011; 22(1) doi: 10.1007/s13337-011-0037-0
|
| 72 |
Kaori Okuyama-Dobashi, Hirotake Kasai, Tomohisa Tanaka, Atsuya Yamashita, Jun Yasumoto, Wenjia Chen, Toru Okamoto, Shinya Maekawa, Koichi Watashi, Takaji Wakita, Akihide Ryo, Tetsuro Suzuki, Yoshiharu Matsuura, Nobuyuki Enomoto, Kohji Moriishi. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. Scientific Reports 2015; 5(1) doi: 10.1038/srep17047
|
| 73 |
Mitchell L. Shiffman. Management of Acute Hepatitis B. Clinics in Liver Disease 2010; 14(1) doi: 10.1016/j.cld.2009.11.013
|
| 74 |
Severin Gudima, Yiping He, Ning Chai, Volker Bruss, Stephan Urban, William Mason, John Taylor. Primary Human Hepatocytes Are Susceptible to Infection by Hepatitis Delta Virus Assembled with Envelope Proteins of Woodchuck Hepatitis Virus. Journal of Virology 2008; 82(15) doi: 10.1128/JVI.00576-08
|
| 75 |
Judith M. White, Sue E. Delos, Matthew Brecher, Kathryn Schornberg. Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme. Critical Reviews in Biochemistry and Molecular Biology 2008; 43(3) doi: 10.1080/10409230802058320
|
| 76 |
André Schmitz, Alexandra Schwarz, Michael Foss, Lixin Zhou, Birgit Rabe, Julia Hoellenriegel, Miriam Stoeber, Nelly Panté, Michael Kann, John Taylor. Nucleoporin 153 Arrests the Nuclear Import of Hepatitis B Virus Capsids in the Nuclear Basket. PLoS Pathogens 2010; 6(1) doi: 10.1371/journal.ppat.1000741
|
| 77 |
Corinna M. Bremer, Irina Sominskaya, Dace Skrastina, Paul Pumpens, Ahmed Abd El Wahed, Ulrike Beutling, Ronald Frank, Hans-Joachim Fritz, Gerhard Hunsmann, Wolfram H. Gerlich, Dieter Glebe. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. Journal of Hepatology 2011; 55(1) doi: 10.1016/j.jhep.2010.10.019
|
| 78 |
Eloi R. Verrier, Che C. Colpitts, Camille Sureau, Thomas F. Baumert. Hepatitis B virus receptors and molecular drug targets. Hepatology International 2016; 10(4) doi: 10.1007/s12072-016-9718-5
|
| 79 |
Fei Xiao, Jane A. McKeating, Thomas F. Baumert. A bile acid transporter as a candidate receptor for hepatitis B and D virus entry. Journal of Hepatology 2013; 58(6) doi: 10.1016/j.jhep.2013.01.036
|
| 80 |
Maribel Cayetano-Cruz, Josefina Valadez-García, Carmen Méndez, Ismael Bustos-Jaimes. Virus-like Nanoparticles Derived from Parvovirus B19 Efficiently Internalize in Human Heptatocytes: A Biocompatible Delivery System for Peptides and Proteins. ACS Applied Nano Materials 2019; 2(10) doi: 10.1021/acsanm.9b01018
|
| 81 |
Spyros Lytras, Gloria Arriagada, Robert J Gifford. Ancient evolution of hepadnaviral paleoviruses and their impact on host genomes. Virus Evolution 2021; 7(1) doi: 10.1093/ve/veab012
|
| 82 |
Stefan Seitz, Jelena Habjanič, Anne K. Schütz, Ralf Bartenschlager. The Hepatitis B Virus Envelope Proteins: Molecular Gymnastics Throughout the Viral Life Cycle. Annual Review of Virology 2020; 7(1) doi: 10.1146/annurev-virology-092818-015508
|
| 83 |
Masashi Iwamoto, Koichi Watashi, Senko Tsukuda, Hussein Hassan Aly, Masayoshi Fukasawa, Akira Fujimoto, Ryosuke Suzuki, Hideki Aizaki, Takayoshi Ito, Osamu Koiwai, Hiroyuki Kusuhara, Takaji Wakita. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochemical and Biophysical Research Communications 2014; 443(3) doi: 10.1016/j.bbrc.2013.12.052
|
| 84 |
Carsten Lambert, Tatjana Döring, Reinhild Prange. Hepatitis B Virus Maturation Is Sensitive to Functional Inhibition of ESCRT-III, Vps4, and γ2-Adaptin. Journal of Virology 2007; 81(17) doi: 10.1128/JVI.00479-07
|
| 85 |
J. Hayer, F. Jadeau, G. Deleage, A. Kay, F. Zoulim, C. Combet. HBVdb: a knowledge database for Hepatitis B Virus. Nucleic Acids Research 2013; 41(D1) doi: 10.1093/nar/gks1022
|
| 86 |
M. L. Op den Brouw, M. A. W. P. De Jong, I. S. Ludwig, R. G. Van Der Molen, H. L. A. Janssen, T. B. H. Geijtenbeek, A. M. Woltman. Branched oligosaccharide structures on HBV prevent interaction with both DC‐SIGN and L‐SIGN. Journal of Viral Hepatitis 2008; 15(9) doi: 10.1111/j.1365-2893.2008.00993.x
|
| 87 |
|
| 88 |
Yann Le Duff, Matthieu Blanchet, Camille Sureau. The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent. Journal of Virology 2009; 83(23) doi: 10.1128/JVI.01594-09
|
| 89 |
Vanessa C. Reese, Claudia E. Oropeza, Alan McLachlan. Independent Activation of Hepatitis B Virus Biosynthesis by Retinoids, Peroxisome Proliferators, and Bile Acids. Journal of Virology 2013; 87(2) doi: 10.1128/JVI.01562-12
|
| 90 |
Charlotte Lepère-Douard, Maud Trotard, Jacques Le Seyec, Philippe Gripon. The First Transmembrane Domain of the Hepatitis B Virus Large Envelope Protein Is Crucial for Infectivity. Journal of Virology 2009; 83(22) doi: 10.1128/JVI.01026-09
|
| 91 |
Andreas Schulze, Kerry Mills, Thomas S. Weiss, Stephan Urban. Hepatocyte Polarization Is Essential for the Productive Entry of the Hepatitis B Virus. Hepatology 2012; 55(2) doi: 10.1002/hep.24707
|
| 92 |
Dieter Glebe, Nora Goldmann, Chris Lauber, Stefan Seitz. HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals. Antiviral Research 2021; 186 doi: 10.1016/j.antiviral.2020.104973
|
| 93 |
Michael Nassal. New Insights into Hbv Replication: New Opportunities for Improved Therapies. Future Virology 2009; 4(1) doi: 10.2217/17460794.4.1.55
|
| 94 |
Dejuan Sun, Lingjuan Zhu, Dahong Yao, Lixia Chen, Leilei Fu, Liang Ouyang. Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives. European Journal of Medicinal Chemistry 2018; 147 doi: 10.1016/j.ejmech.2018.02.001
|
| 95 |
Sarah Cohen, Shelly Au, Nelly Panté. How viruses access the nucleus. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011; 1813(9) doi: 10.1016/j.bbamcr.2010.12.009
|
| 96 |
Bozena Walewska-Zielecka, Kazimierz Madalinski, Joanna Jablonska, Paulina Godzik, Joanna Cielecka-Kuszyk, Bogumila Litwinska. Composition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression. World Journal of Gastroenterology 2008; 14(25): 4040-4046 doi: 10.3748/wjg.14.4040
|
| 97 |
K.W. Lee, B.T. Tey, K.L. Ho, W.S. Tan. Delivery of chimeric hepatitis B core particles into liver cells. Journal of Applied Microbiology 2012; 112(1) doi: 10.1111/j.1365-2672.2011.05176.x
|
| 98 |
Ziying Han, Shoko Nogusa, Emmanuelle Nicolas, Siddharth Balachandran, John Taylor, Wang-Shick Ryu. Interferon Impedes an Early Step of Hepatitis Delta Virus Infection. PLoS ONE 2011; 6(7) doi: 10.1371/journal.pone.0022415
|
| 99 |
Manabu Kaneko, Yushi Futamura, Senko Tsukuda, Yasumitsu Kondoh, Tomomi Sekine, Hiroyuki Hirano, Kento Fukano, Hirofumi Ohashi, Wakana Saso, Ryo Morishita, Satoko Matsunaga, Fumihiro Kawai, Akihide Ryo, Sam-Yong Park, Ryosuke Suzuki, Hideki Aizaki, Naoko Ohtani, Camille Sureau, Takaji Wakita, Hiroyuki Osada, Koichi Watashi. Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20987-w
|
| 100 |
Felix Lehmann, Heiko Slanina, Martin Roderfeld, Elke Roeb, Jonel Trebicka, John Ziebuhr, Wolfram H. Gerlich, Christian G. Schüttler, Bernhard Schlevogt, Dieter Glebe. A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape. Viruses 2023; 15(4) doi: 10.3390/v15040838
|
| 101 |
|
| 102 |
Junpei Hara, Yuka Tanaka, Hiroto Kaneko, Yoshito Itoh, Hiroshi Ikegaya. Detection of hepatitis B virus DNA and HBsAg from postmortem blood and bloodstains. Archives of Virology 2018; 163(3) doi: 10.1007/s00705-017-3665-x
|
| 103 |
Riki Toita, Takahito Kawano, Jeong-Hun Kang, Masaharu Murata. Applications of human hepatitis B virus preS domain in bio- and nanotechnology. World Journal of Gastroenterology 2015; 21(24): 7400-7411 doi: 10.3748/wjg.v21.i24.7400
|
| 104 |
Chiao-Fang Teng, Han-Chieh Wu, Ih-Jen Su, Long-Bin Jeng. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma. Viruses 2020; 12(9) doi: 10.3390/v12090945
|
| 105 |
Kai Dallmeier, Ursula Schultz, Michael Nassal, Donald E. Ganem. Heterologous Replacement of the Supposed Host Determining Region of Avihepadnaviruses: High In Vivo Infectivity Despite Low Infectivity for Hepatocytes. PLoS Pathogens 2008; 4(12) doi: 10.1371/journal.ppat.1000230
|
| 106 |
X.-L. Zhou, P.-N. Sun, T.-H. Huang, Q.-D. Xie, X.-J. Kang, L.-M. Liu. Effects of hepatitis B virus S protein on human sperm function. Human Reproduction 2009; 24(7) doi: 10.1093/humrep/dep050
|
| 107 |
Simran Sharma, Preety Rawal, Savneet Kaur, Rekha Puria. Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review. Experimental Cell Research 2023; 428(1) doi: 10.1016/j.yexcr.2023.113618
|
| 108 |
Shirin Nkongolo, Yi Ni, Florian A. Lempp, Christina Kaufman, Thomas Lindner, Katharina Esser-Nobis, Volker Lohmann, Walter Mier, Stefan Mehrle, Stephan Urban. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. Journal of Hepatology 2014; 60(4) doi: 10.1016/j.jhep.2013.11.022
|
| 109 |
Clément Guillot, Nora Martel, Françoise Berby, Isabelle Bordes, Olivier Hantz, Matthieu Blanchet, Camille Sureau, Andrew Vaillant, Isabelle Chemin, Sibnarayan Datta. Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes. PLOS ONE 2017; 12(6) doi: 10.1371/journal.pone.0179697
|
| 110 |
Guangwei Xu, Zhenchao Gao, Wenhui He, Yanting Ma, Xiaofeng Feng, Tao Cai, Fengmin Lu, Li Liu, Wenhui Li. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture. Virology 2014; 448 doi: 10.1016/j.virol.2013.10.016
|
| 111 |
Michael Nassal. Hepatitis B viruses: Reverse transcription a different way. Virus Research 2008; 134(1-2) doi: 10.1016/j.virusres.2007.12.024
|
| 112 |
Stefan Seitz, Stephan Urban, Christoph Antoni, Bettina Böttcher. Cryo‐electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. The EMBO Journal 2007; 26(18) doi: 10.1038/sj.emboj.7601841
|
| 113 |
Yong-Song Guan, Qing He, Ming-Quan Wang, Ping Li. Nuclear factor kappa B and hepatitis viruses. Expert Opinion on Therapeutic Targets 2008; 12(3) doi: 10.1517/14728222.12.3.265
|
| 114 |
Shuping Tong, Jisu Li. Identification of NTCP as an HBV Receptor: The Beginning of the End or the End of the Beginning?. Gastroenterology 2014; 146(4) doi: 10.1053/j.gastro.2014.02.024
|
| 115 |
Xuan Liu, Lunzhi Yuan, Liang Zhang, Yalin Mu, Xiaoling Li, Chao Liu, Peng Lv, Yali Zhang, Tong Cheng, Quan Yuan, Ningshao Xia, Xiaoyuan Chen, Gang Liu. Bioinspired Artificial Nanodecoys for Hepatitis B Virus. Angewandte Chemie 2018; 130(38) doi: 10.1002/ange.201807212
|
| 116 |
Jennifer A. Dill, Alvin C. Camus, John H. Leary, Francesca Di Giallonardo, Edward C. Holmes, Terry Fei Fan Ng, J.-H. J. Ou. Distinct Viral Lineages from Fish and Amphibians Reveal the Complex Evolutionary History of Hepadnaviruses. Journal of Virology 2016; 90(17) doi: 10.1128/JVI.00832-16
|
| 117 |
Jakub Chojnacki, Elizabeth VL Grgacic. Enveloped Viral Fusion: Insights into the Fusion of Hepatitis b Viruses. Future Virology 2008; 3(6) doi: 10.2217/17460794.3.6.543
|
| 118 |
Jing Yang, Feng Wang, Linlin Tian, Jing Su, Xiangqian Zhu, Li Lin, Xiaoran Ding, Xuejun Wang, Shengqi Wang. Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface. Archives of Virology 2010; 155(6) doi: 10.1007/s00705-010-0657-5
|
| 119 |
Jisu Li, Li Zong, Camille Sureau, Luke Barker, Jack R. Wands, Shuping Tong, G. McFadden. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor. Journal of Virology 2016; 90(18) doi: 10.1128/JVI.01153-16
|
| 120 |
Darong Xu, Hongliang Bian, Jinlan Cai, Daocheng Bao, Qing Jin, Min Zhu, Cuifeng Zhang, Tingting Tao. Computational design of peptide ligands to target the intermolecular interaction between viral envelope protein and pediatric receptor. Computational Biology and Chemistry 2017; 69 doi: 10.1016/j.compbiolchem.2017.06.001
|
| 121 |
Stephanie Schädler, Eberhard Hildt. HBV Life Cycle: Entry and Morphogenesis. Viruses 2009; 1(2) doi: 10.3390/v1020185
|
| 122 |
Susanne Modrow, Dietrich Falke, Uwe Truyen, Hermann Schätzl. Molekulare Virologie. 2010; doi: 10.1007/978-3-8274-2241-5_19
|
| 123 |
Rong‐Hwa Jan, Yu‐Li Lin, Chia‐Jung Chen, Teng‐Yi Lin, Ya‐Chun Hsu, Li‐Kuang Chen, Bor‐Luen Chiang. Hepatitis B virus surface antigen can activate human monocyte‐derived dendritic cells by nuclear factor kappa B and p38 mitogen‐activated protein kinase mediated signaling. Microbiology and Immunology 2012; 56(10) doi: 10.1111/j.1348-0421.2012.00496.x
|
| 124 |
Karin Awe, Carsten Lambert, Reinhild Prange. Mammalian BiP controls posttranslational ER translocation of the hepatitis B virus large envelope protein. FEBS Letters 2008; 582(21-22) doi: 10.1016/j.febslet.2008.07.062
|
| 125 |
F.H. Pujol, R. Jaspe, C. Trépo, I. Chemin. Prise en charge du porteur de l’antigène HBs. EMC - Hépatologie 2025; 40(4) doi: 10.1016/S1155-1976(24)86132-6
|
| 126 |
Jack Thomas Bell, Xiaonan Zhang. The hepatitis B virus surface antigen: An evolved perfection and its unresolved mysteries. Virology 2025; 608 doi: 10.1016/j.virol.2025.110527
|
| 127 |
Charline Herrscher, Philippe Roingeard, Emmanuelle Blanchard. Hepatitis B Virus Entry into Cells. Cells 2020; 9(6) doi: 10.3390/cells9061486
|
| 128 |
Hongtao Liu, Dariusz Zakrzewicz, Kamil Nosol, Rossitza N. Irobalieva, Somnath Mukherjee, Rose Bang-Sørensen, Nora Goldmann, Sebastian Kunz, Lorenzo Rossi, Anthony A. Kossiakoff, Stephan Urban, Dieter Glebe, Joachim Geyer, Kaspar P. Locher. Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-46706-w
|
| 129 |
Carmen L. Delgado, Elena Núñez, Belén Yélamos, Julián Gómez-Gutiérrez, Darrell L. Peterson, Francisco Gavilanes. Study of the putative fusion regions of the preS domain of hepatitis B virus. Biochimica et Biophysica Acta (BBA) - Biomembranes 2015; 1848(4) doi: 10.1016/j.bbamem.2014.12.020
|
| 130 |
Lanish Singh, Trevor Graham Bell, Mukhlid Yousif, Anna Kramvis. Response of hepatitis B virus to antiretroviral treatment containing lamivudine in HBsAg‐positive and HBsAg‐negative HIV‐positive South African adults. Journal of Medical Virology 2019; 91(5) doi: 10.1002/jmv.25375
|
| 131 |
Andreas Schulze, Alexa Schieck, Yi Ni, Walter Mier, Stephan Urban. Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction. Journal of Virology 2010; 84(4) doi: 10.1128/JVI.01902-09
|
| 132 |
Vanessa C. Reese, David D. Moore, Alan McLachlan.
Limited Effects of Bile Acids and Small Heterodimer Partner on Hepatitis B Virus Biosynthesis
In Vivo
. Journal of Virology 2012; 86(5) doi: 10.1128/JVI.06742-11
|
| 133 |
So-Young Kim, Eungyeong Jang, Kyung-Soo Inn. The Role of Sodium-taurocholate Co-transporting Polypeptide as a Receptor during HBV Infection. Journal of Bacteriology and Virology 2016; 46(4) doi: 10.4167/jbv.2016.46.4.335
|
| 134 |
Thomas Tu, Stephan Urban. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections. Current Opinion in Virology 2018; 30 doi: 10.1016/j.coviro.2018.04.004
|
| 135 |
Fiona van den Berg, Shonisani Wendy Limani, Njabulo Mnyandu, Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot. Advances with RNAi-Based Therapy for Hepatitis B Virus Infection. Viruses 2020; 12(8) doi: 10.3390/v12080851
|
| 136 |
Y. Xie, J. Zhai, Q. Deng, P. Tiollais, Y. Wang, M. Zhao. Entry of hepatitis B virus: Mechanism and new therapeutic target. Pathologie Biologie 2010; 58(4) doi: 10.1016/j.patbio.2010.04.001
|
| 137 |
Wei-Ling Lin, Jui-Hsiang Hung, Wenya Huang. Association of the Hepatitis B Virus Large Surface Protein with Viral Infectivity and Endoplasmic Reticulum Stress-mediated Liver Carcinogenesis. Cells 2020; 9(9) doi: 10.3390/cells9092052
|
| 138 |
Susanne Modrow, Uwe Truyen, Hermann Schätzl. Molekulare Virologie. 2021; doi: 10.1007/978-3-662-61781-6_18
|
| 139 |
Yong-Wei Li, Feng-Cai Yang, Hui-Qiong Lu, Jiong-Shan Zhang. Hepatocellular carcinoma and hepatitis B surface protein. World Journal of Gastroenterology 2016; 22(6): 1943-1952 doi: 10.3748/wjg.v22.i6.1943
|
| 140 |
Jisu Li, Shuping Tong. From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor. Clinical and Molecular Hepatology 2015; 21(3) doi: 10.3350/cmh.2015.21.3.193
|
| 141 |
Jessica Salisse, Camille Sureau. A Function Essential to Viral Entry Underlies the Hepatitis B Virus “a” Determinant. Journal of Virology 2009; 83(18) doi: 10.1128/JVI.00678-09
|
| 142 |
Wenhui Li, Stephan Urban. Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications. Journal of Hepatology 2016; 64(1) doi: 10.1016/j.jhep.2016.02.011
|
| 143 |
Antonia Alexandra Evripioti, Ana Maria Ortega-Prieto, Jessica Katy Skelton, Quentin Bazot, Marcus Dorner. Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection. Philosophical Transactions of the Royal Society B: Biological Sciences 2019; 374(1773) doi: 10.1098/rstb.2018.0292
|
| 144 |
Carolina Alves, Cristina Branco, Celso Cunha. Hepatitis Delta Virus: A Peculiar Virus. Advances in Virology 2013; 2013 doi: 10.1155/2013/560105
|
| 145 |
Anja Meier, Stefan Mehrle, Thomas S. Weiss, Walter Mier, Stephan Urban. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology 2013; 58(1) doi: 10.1002/hep.26181
|
| 146 |
Zhenzhen Su, Yi Li, Yun Liao, Bei Cai, Jie Chen, Junlong Zhang, Lixin Li, Binwu Ying, Chuanmin Tao, Lanlan Wang. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population. Infection, Genetics and Evolution 2014; 27 doi: 10.1016/j.meegid.2014.07.001
|
| 147 |
Ning Chai, Ho Eun Chang, Emmanuelle Nicolas, Severin Gudima, Jinhong Chang, John Taylor. Assembly of Hepatitis B Virus Envelope Proteins onto a Lentivirus Pseudotype That Infects Primary Human Hepatocytes. Journal of Virology 2007; 81(20) doi: 10.1128/JVI.00959-07
|
| 148 |
Huan Yan, Guocai Zhong, Guangwei Xu, Wenhui He, Zhiyi Jing, Zhenchao Gao, Yi Huang, Yonghe Qi, Bo Peng, Haimin Wang, Liran Fu, Mei Song, Pan Chen, Wenqing Gao, Bijie Ren, Yinyan Sun, Tao Cai, Xiaofeng Feng, Jianhua Sui, Wenhui Li. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012; 1 doi: 10.7554/eLife.00049
|
| 149 |
|
| 150 |
Hung-Chih Yang, Shiou-Hwei Yeh, Pei-Jer Chen, Ding-Shinn Chen. Viruses and Human Cancer. 2014; doi: 10.1007/978-1-4939-0870-7_6
|
| 151 |
Jia Li, Yong Lin, Xueyu Wang, Mengji Lu. Interconnection of cellular autophagy and endosomal vesicle trafficking and its role in hepatitis B virus replication and release. Virologica Sinica 2024; 39(1) doi: 10.1016/j.virs.2024.01.001
|
| 152 |
Jia Song, Xiaochao Zhang, Qianyun Ge, Chaoyi Yuan, Liang Chu, Hui‐fang Liang, Zhibin Liao, Qiumeng Liu, Zhanguo Zhang, Bixiang Zhang. CRISPR/Cas9‐mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV‐positive hepatocellular carcinoma cells. Journal of Cellular Biochemistry 2018; 119(10) doi: 10.1002/jcb.27050
|
| 153 |
Andrea M. Woltman, Marjoleine L. Op den Brouw, Paula J. Biesta, Cui C. Shi, Harry L. A. Janssen, Heiner Wedemeyer. Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function. PLoS ONE 2011; 6(1) doi: 10.1371/journal.pone.0015324
|
| 154 |
Yeping Sun, Shanshan Wang, Yong Yi, Jing Zhang, Zhongping Duan, Kehu Yuan, Wenjun Liu, Jing Li, Yiping Zhu. The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry. Frontiers in Cellular and Infection Microbiology 2018; 8 doi: 10.3389/fcimb.2018.00338
|
| 155 |
A M Woltman, A Boonstra, H L A Janssen. Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?. Gut 2010; 59(01) doi: 10.1136/gut.2009.181040
|
| 156 |
Dominik Witzigmann, Philipp Uhl, Sandro Sieber, Christina Kaufman, Tomaz Einfalt, Katrin Schöneweis, Philip Grossen, Jonas Buck, Yi Ni, Susanne H Schenk, Janine Hussner, Henriette E Meyer zu Schwabedissen, Gabriela Québatte, Walter Mier, Stephan Urban, Jörg Huwyler. Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide. eLife 2019; 8 doi: 10.7554/eLife.42276
|
| 157 |
Shaik Khasimbi, Faraat Ali, Kiran Manda, Anjali Sharma, Garima Chauhan, Sharad Wakode. Dihydropyrimidinones Scaffold as a Promising Nucleus for Synthetic Profile and Various Therapeutic Targets: A Review. Current Organic Synthesis 2021; 18(3) doi: 10.2174/1570179417666201207215710
|
| 158 |
Masashi Ninomiya, Jun Inoue, Eugene W. Krueger, Jing Chen, Hong Cao, Atsushi Masamune, Mark A. McNiven. The Exosome‐Associated Tetraspanin CD63 Contributes to the Efficient Assembly and Infectivity of the Hepatitis B Virus. Hepatology Communications 2021; 5(7) doi: 10.1002/hep4.1709
|
| 159 |
Massimiliano Paganelli, Kai Dallmeier, Omar Nyabi, Isabelle Scheers, Benoît Kabamba, Johan Neyts, Patrick Goubau, Mustapha Najimi, Etienne M. Sokal. Differentiated umbilical cord matrix stem cells as a new in vitro model to study early events during hepatitis B virus infection. Hepatology 2013; 57(1) doi: 10.1002/hep.26006
|
| 160 |
Nadia Warner, Stephen Locarnini. The new front-line in hepatitis B/D research: Identification and blocking of a functional receptor. Hepatology 2013; 58(1) doi: 10.1002/hep.26292
|
| 161 |
Georges Abou-Jaoudé, Camille Sureau. Entry of Hepatitis Delta Virus Requires the Conserved Cysteine Residues of the Hepatitis B Virus Envelope Protein Antigenic Loop and Is Blocked by Inhibitors of Thiol-Disulfide Exchange. Journal of Virology 2007; 81(23) doi: 10.1128/JVI.01495-07
|
| 162 |
Kenichi Morikawa, Goki Suda, Naoya Sakamoto. Viral life cycle of hepatitis B virus: Host factors and druggable targets. Hepatology Research 2016; 46(9) doi: 10.1111/hepr.12650
|
| 163 |
C Nelson Hayes, Yizhou Zhang, Grace Naswa Makokha, Md Zobaer Hasan, Magot D Omokoko, Kazuaki Chayama. Early events in hepatitis B virus infection: From the cell surface to the nucleus. Journal of Gastroenterology and Hepatology 2016; 31(2) doi: 10.1111/jgh.13175
|
| 164 |
Corinna M. Leistner, Stefanie Gruen-Bernhard, Dieter Glebe. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cellular Microbiology 2007; 0(0) doi: 10.1111/j.1462-5822.2007.01023.x
|
| 165 |
Stanca M. Ciupe, Ruy M. Ribeiro, Alan S. Perelson, Roland R. Regoes. Antibody Responses during Hepatitis B Viral Infection. PLoS Computational Biology 2014; 10(7) doi: 10.1371/journal.pcbi.1003730
|
| 166 |
C. Nelson Hayes, Kazuaki Chayama. Hepatitis B Virus and Liver Disease. 2021; doi: 10.1007/978-981-16-3615-8_2
|
| 167 |
Md. Golzar Hossain, Md. Muket Mahmud, K. H. M. Nazmul Hussain Nazir, Keiji Ueda. PreS1 Mutations Alter the Large HBsAg Antigenicity of a Hepatitis B Virus Strain Isolated in Bangladesh. International Journal of Molecular Sciences 2020; 21(2) doi: 10.3390/ijms21020546
|
| 168 |
Thomas Müller, Stefan Mehrle, Alexa Schieck, Uwe Haberkorn, Stephan Urban, Walter Mier. Liver Imaging with a Novel Hepatitis B Surface Protein Derived SPECT-Tracer. Molecular Pharmaceutics 2013; 10(6) doi: 10.1021/mp400038r
|
| 169 |
Natalia Freitas, Celso Cunha, Stephan Menne, Severin O. Gudima, G. McFadden. Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles. Journal of Virology 2014; 88(10) doi: 10.1128/JVI.00430-14
|
| 170 |
Izabela Sokolowska, Cristina Dorobantu, Alisa G Woods, Alina Macovei, Norica Branza-Nichita, Costel C Darie. Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells. Proteome Science 2012; 10(1) doi: 10.1186/1477-5956-10-47
|
| 171 |
Qinghong Wang, Jijun Zhou, Bei Zhang, Zhiqiang Tian, Jun Tang, Yanhua Zheng, Zemin Huang, Yi Tian, Zhengcai Jia, Yan Tang, Jennifer C. van Velkinburgh, Qing Mao, Xiuwu Bian, Yifang Ping, Bing Ni, Yuzhang Wu, Aleem Siddiqui. Hepatitis B Virus Induces IL-23 Production in Antigen Presenting Cells and Causes Liver Damage via the IL-23/IL-17 Axis. PLoS Pathogens 2013; 9(6) doi: 10.1371/journal.ppat.1003410
|
| 172 |
Patricia A. Pesavento, Kenneth Jackson, Timothy Scase, Tiffany Tse, Bronte Hampson, John S. Munday, Vanessa R. Barrs, Julia A. Beatty. A Novel Hepadnavirus is Associated with Chronic Hepatitis and Hepatocellular Carcinoma in Cats. Viruses 2019; 11(10) doi: 10.3390/v11100969
|
| 173 |
Faseeha Noordeen. Hepatitis B virus infection: An insight into infection outcomes and recent treatment options. VirusDisease 2015; 26(1-2) doi: 10.1007/s13337-015-0247-y
|
| 174 |
Jan Felix Drexler, Andreas Geipel, Alexander König, Victor M. Corman, Debby van Riel, Lonneke M. Leijten, Corinna M. Bremer, Andrea Rasche, Veronika M. Cottontail, Gael D. Maganga, Mathias Schlegel, Marcel A. Müller, Alexander Adam, Stefan M. Klose, Aroldo José Borges Carneiro, Andreas Stöcker, Carlos Roberto Franke, Florian Gloza-Rausch, Joachim Geyer, Augustina Annan, Yaw Adu-Sarkodie, Samuel Oppong, Tabea Binger, Peter Vallo, Marco Tschapka, Rainer G. Ulrich, Wolfram H. Gerlich, Eric Leroy, Thijs Kuiken, Dieter Glebe, Christian Drosten. Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proceedings of the National Academy of Sciences 2013; 110(40) doi: 10.1073/pnas.1308049110
|
| 175 |
Qin Hu, Feifei Zhang, Liang Duan, Bo Wang, Yuanyuan Ye, Pu Li, Dandan Li, Shengjun Yang, Lan Zhou, Weixian Chen. E-cadherin Plays a Role in Hepatitis B Virus Entry Through Affecting Glycosylated Sodium-Taurocholate Cotransporting Polypeptide Distribution. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00074
|
| 176 |
Motswedi Anderson, Simani Gaseitsiwe, Sikhulile Moyo, Matthijs J. C. Wessels, Terence Mohammed, Theresa K. Sebunya, Eleanor A. Powell, Joseph Makhema, Jason T. Blackard, Richard Marlink, Max Essex, Rosemary M. Musonda. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana. BMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-1096-4
|
| 177 |
Xiaoli Ye, Ming Zhou, Yonggang He, Yanmin Wan, Weiya Bai, Shuai Tao, Yanqin Ren, Xinxin Zhang, Jianqing Xu, Jing Liu, Junqi Zhang, Kanghong Hu, Youhua Xie. Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide. Scientific Reports 2016; 6(1) doi: 10.1038/srep29391
|
| 178 |
Natalia Freitas, Kenji Abe, Celso Cunha, Stephan Menne, Severin O. Gudima, G. McFadden. Support of the Infectivity of Hepatitis Delta Virus Particles by the Envelope Proteins of Different Genotypes of Hepatitis B Virus. Journal of Virology 2014; 88(11) doi: 10.1128/JVI.00346-14
|
| 179 |
John M. Taylor, Ziying Han, Wang-Shick Ryu. Purinergic Receptor Functionality Is Necessary for Infection of Human Hepatocytes by Hepatitis Delta Virus and Hepatitis B Virus. PLoS ONE 2010; 5(12) doi: 10.1371/journal.pone.0015784
|
| 180 |
Fabien Abdul, Bénédicte Ndeboko, Thierry Buronfosse, Fabien Zoulim, Michael Kann, Peter E. Nielsen, Lucyna Cova, Wang-Shick Ryu. Potent Inhibition of Late Stages of Hepadnavirus Replication by a Modified Cell Penetrating Peptide. PLoS ONE 2012; 7(11) doi: 10.1371/journal.pone.0048721
|
| 181 |
Reinhild Prange. Host factors involved in hepatitis B virus maturation, assembly, and egress. Medical Microbiology and Immunology 2012; 201(4) doi: 10.1007/s00430-012-0267-9
|
| 182 |
Takeshi Kasuya, Shintaro Nomura, Takashi Matsuzaki, Joohee Jung, Tadanori Yamada, Kenji Tatematsu, Toshihide Okajima, Katsuyuki Tanizawa, Shun’ichi Kuroda. Expression of squamous cell carcinoma antigen‐1 in liver enhances the uptake of hepatitis B virus envelope‐derived bio‐nanocapsules in transgenic rats. The FEBS Journal 2008; 275(22) doi: 10.1111/j.1742-4658.2008.06698.x
|
| 183 |
Philipp Uhl, Gert Fricker, Uwe Haberkorn, Walter Mier. Current Status in the Therapy of Liver Diseases. International Journal of Molecular Sciences 2014; 15(5) doi: 10.3390/ijms15057500
|
| 184 |
Francisco Rodríguez-Frias, Rosendo Jardi. Virología molecular del virus de la hepatitis B. Enfermedades Infecciosas y Microbiología Clínica 2008; 26 doi: 10.1016/S0213-005X(08)76514-5
|
| 185 |
Duo Shi, Yan Zhang, Bing Luo. A review: cellular attachment and entry factors of human tumor-associated viruses. Future Virology 2024; 19(2-4) doi: 10.1080/17460794.2024.2342135
|
| 186 |
Zhenfeng Zhang, Benno Zehnder, Christine Damrau, Stephan Urban. Visualization of hepatitis B virus entry – novel tools and approaches to directly follow virus entry into hepatocytes. FEBS Letters 2016; 590(13) doi: 10.1002/1873-3468.12202
|
| 187 |
Dieter Glebe, Andreas Geipel. Selected Phenotypic Assays Used to Evaluate Antiviral Resistance and Viral Fitness of Hepatitis B Virus and Its Variants. Intervirology 2014; 57(3-4) doi: 10.1159/000360950
|
| 188 |
Joohee Jung, Takashi Matsuzaki, Kenji Tatematsu, Toshihide Okajima, Katsuyuki Tanizawa, Shun'ichi Kuroda. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. Journal of Controlled Release 2008; 126(3) doi: 10.1016/j.jconrel.2007.12.002
|
| 189 |
Chan Xie, Yu‐Bao Zheng, Hai‐Peng Zhu, Liang Peng, Zhi‐Liang Gao. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro. Cell Biology International 2009; 33(4) doi: 10.1016/j.cellbi.2009.01.006
|
| 190 |
J.W. Zea-Mazo, Y.A. Negrette-Mejía, W. Cardona-Maya. Virus de transmisión sexual: relación semen y virus. Actas Urológicas Españolas 2010; 34(10) doi: 10.1016/j.acuro.2010.07.002
|
| 191 |
Breno Frederico de Carvalho Dominguez Souza, Jan Felix Drexler, Renato Santos de Lima, Mila de Oliveira Hughes Veiga do Rosário, Eduardo Martins Netto. Theories about evolutionary origins of human hepatitis B virus in primates and humans. The Brazilian Journal of Infectious Diseases 2014; 18(5) doi: 10.1016/j.bjid.2013.12.006
|
| 192 |
Duo Shi, Yan Zhang, Bing Luo. A review: cellular attachment and entry factors of human tumor-associated viruses. Future Virology 2024; 19(2-4) doi: 10.1080/17460794.2024.2342135
|
| 193 |
Elham Shirvani-Dastgerdi, Benjamin Y. Winer, Toni Celià-Terrassa, Yibin Kang, David Tabernero, Eray Yagmur, Francisco Rodríguez-Frías, Josep Gregori, Tom Luedde, Christian Trautwein, Alexander Ploss, Frank Tacke. Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy. Journal of Hepatology 2017; 67(2) doi: 10.1016/j.jhep.2017.03.027
|
| 194 |
Maura Dandri, Joerg Petersen. <p>cccDNA Maintenance in Chronic Hepatitis B – Targeting the Matrix of Viral Replication</p>. Infection and Drug Resistance 2020; doi: 10.2147/IDR.S240472
|
| 195 |
Keiji Ueda, Yadarat Suwanmanee. ATP5B Is an Essential Factor for Hepatitis B Virus Entry. International Journal of Molecular Sciences 2022; 23(17) doi: 10.3390/ijms23179570
|
| 196 |
Xiao-Ling Zhou, Gareth J. Sullivan, Pingnan Sun, In-Hyun Park. Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Archives of Pharmacal Research 2012; 35(2) doi: 10.1007/s12272-012-0206-8
|
| 197 |
Daniel Puntener, Urs F. Greber. DNA-tumor virus entry—From plasma membrane to the nucleus. Seminars in Cell & Developmental Biology 2009; 20(5) doi: 10.1016/j.semcdb.2009.03.014
|
| 198 |
|
| 199 |
Yuka Hayashi, Kazuto Tajiri, Tatsuhiko Ozawa, Kiyohiko Angata, Takashi Sato, Akira Togayachi, Izuru Nagashima, Hiroki Shimizu, Aiko Murayama, Nozomu Muraishi, Hisashi Narimatsu, Ichiro Yasuda. Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection. Medicina 2024; 60(8) doi: 10.3390/medicina60081334
|
| 200 |
Xinyan Yao, Chaoxiang Jia, Anqi Li, Ting Qin, Dai Peng, Yingqian Han, Shuang Guo, Kai Zhong, Guoyu Yang, Yueying Wang, Heping Li. Epidemiology and genotypic diversity of duck hepatitis B virus identified from waterfowl in partial areas of Guangdong province, Southern China. Virology 2025; 603 doi: 10.1016/j.virol.2025.110416
|
| 201 |
Caitlin R. Ondracek, Christel N. Rushing, Vanessa C. Reese, Claudia E. Oropeza, Alan McLachlan. Peroxisome Proliferator-Activated Receptor γ Coactivator 1α and Small Heterodimer Partner Differentially Regulate Nuclear Receptor-Dependent Hepatitis B Virus Biosynthesis. Journal of Virology 2009; 83(23) doi: 10.1128/JVI.01623-09
|
| 202 |
Azza Masoud Abdelbaky Ahmed, Hanan Abdelftah Temerk, Hamdi Ramdan Galal, Shamardan Ezzeldin S. Bazeed, Serageldeen Sultan. The seropervelance of infectious hepatitis viruses (HBV, HCV and HEV) among blood donors and their correlation to risk factors in Qena governorate, Upper Egypt. VirusDisease 2020; 31(3) doi: 10.1007/s13337-020-00589-9
|
| 203 |
Thomas F Baumert, Eloi R Verrier, Michael Nassal, Raymond T Chung, Mirjam B Zeisel. Host-targeting agents for treatment of hepatitis B virus infection. Current Opinion in Virology 2015; 14 doi: 10.1016/j.coviro.2015.07.009
|
| 204 |
|
| 205 |
Huan Yan, Wenhui Li. Sodium Taurocholate Cotransporting Polypeptide Acts as a Receptor for Hepatitis B and D Virus. Digestive Diseases 2015; 33(3) doi: 10.1159/000371692
|
| 206 |
Dake Zhang, Peiling Dong, Ke Zhang, Libin Deng, Christian Bach, Wei Chen, Feifei Li, Ulrike Protzer, Huiguo Ding, Changqing Zeng. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment. BMC Microbiology 2012; 12(1) doi: 10.1186/1471-2180-12-307
|
| 207 |
|
| 208 |
Takeshi Kasuya, Shun'ichi Kuroda. Nanoparticles for human liver-specific drug and gene delivery systems:in vitroandin vivoadvances. Expert Opinion on Drug Delivery 2009; 6(1) doi: 10.1517/17425240802622096
|
| 209 |
Min Lian, Xu Zhou, Bin Chen, Chan Li, Xiaocheng Gu, Ming Luo, Xiaofeng Zheng. Identification of the critical regions in hepatitis B virus preS required for its stability. Journal of Peptide Science 2008; 14(3) doi: 10.1002/psc.929
|
| 210 |
Junyu Lin, Jing Li, Peilin Xie, Yue Han, Demin Yu, Jia Chen, Xinxin Zhang. Hepatitis B virus middle surface antigen loss promotes clinical variant persistence in mouse models. Virulence 2021; 12(1) doi: 10.1080/21505594.2021.1999130
|
| 211 |
Zaira Rehman, Ammad Fahim, Hajra Sadia. Deciphering the mystery of hepatitis B virus receptors: A historical perspective. VirusDisease 2015; 26(3) doi: 10.1007/s13337-015-0260-1
|
| 212 |
Wenhui Li. The Hepatitis B Virus Receptor. Annual Review of Cell and Developmental Biology 2015; 31(1) doi: 10.1146/annurev-cellbio-100814-125241
|
| 213 |
M. Sawkat Anwer, Bruno Stieger. Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters. Pflügers Archiv - European Journal of Physiology 2014; 466(1) doi: 10.1007/s00424-013-1367-0
|
| 214 |
Stephan Urban. New Insights into Hepatitis B and Hepatitis Delta Virus Entry. Future Virology 2008; 3(3) doi: 10.2217/17460794.3.3.253
|
| 215 |
Thomas F Baumert, Luke Meredith, Yi Ni, Daniel J Felmlee, Jane A McKeating, Stephan Urban. Entry of hepatitis B and C viruses — recent progress and future impact. Current Opinion in Virology 2014; 4 doi: 10.1016/j.coviro.2013.12.002
|
| 216 |
Camille Sureau, Jessica Salisse. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant. Hepatology 2013; 57(3) doi: 10.1002/hep.26125
|
| 217 |
Parham Sahandi Zangabad, Mahdi Karimi, Fatemeh Mehdizadeh, Hedieh Malekzad, Alireza Ghasemi, Sajad Bahrami, Hossein Zare, Mohsen Moghoofei, Amin Hekmatmanesh, Michael R. Hamblin. Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger. Nanoscale 2017; 9(4) doi: 10.1039/C6NR07315H
|
| 218 |
Kuifeng Wang, Chunying Yang, Gang Lin, Gengge Wang, Jiansheng Zhu. Structure-based rational design of peptide inhibitors to disrupt the recognition and interaction between hepatitis B virus large envelope protein and human hepatocyte receptor γ2-adaptin. Medicinal Chemistry Research 2017; 26(11) doi: 10.1007/s00044-017-1981-z
|